These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 35727598)
1. Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma. Noh JJ; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Choi JY; Lee JW Clin Cancer Res; 2022 Sep; 28(17):3850-3861. PubMed ID: 35727598 [TBL] [Abstract][Full Text] [Related]
2. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma. Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma. Lee HHY; Chow KL; Wong HS; Chong TY; Wong AST; Cheng GHW; Ko JMK; Siu HC; Yeung MCF; Huen MSY; Tse KY; Bray MR; Mak TW; Leung SY; Ip PPC Clin Cancer Res; 2024 Sep; 30(17):3904-3918. PubMed ID: 38848043 [TBL] [Abstract][Full Text] [Related]
4. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma. Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789 [TBL] [Abstract][Full Text] [Related]
5. A nutrient mixture reduced tumor growth of SK-UT-1 human leiomyosarcoma cells in vivo and in vitro by inhibiting MMPs and inducing apoptosis. Roomi MW; Bhanap B; Niedzwiecki A; Rath M Exp Oncol; 2021 Sep; 43(3):209-216. PubMed ID: 34591419 [TBL] [Abstract][Full Text] [Related]
6. Sensitivity of neuroblastoma to the novel kinase inhibitor cabozantinib is mediated by ERK inhibition. Zhang L; Scorsone K; Woodfield SE; Zage PE Cancer Chemother Pharmacol; 2015 Nov; 76(5):977-87. PubMed ID: 26407819 [TBL] [Abstract][Full Text] [Related]
7. Copper ions are novel therapeutic agents for uterine leiomyosarcoma. Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063 [TBL] [Abstract][Full Text] [Related]
8. Curcumin induces cross-regulation between autophagy and apoptosis in uterine leiomyosarcoma cells. Li B; Takeda T; Tsuiji K; Wong TF; Tadakawa M; Kondo A; Nagase S; Yaegashi N Int J Gynecol Cancer; 2013 Jun; 23(5):803-8. PubMed ID: 23532091 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model. Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915 [TBL] [Abstract][Full Text] [Related]
10. Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. Eskander RN; Randall LM; Sakai T; Guo Y; Hoang B; Zi X J Obstet Gynaecol Res; 2012 Aug; 38(8):1086-94. PubMed ID: 22540374 [TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway. Chen S; Yao L Cancer Chemother Pharmacol; 2021 Aug; 88(2):323-334. PubMed ID: 33978839 [TBL] [Abstract][Full Text] [Related]
12. Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity. Wang X; Huang Y; Christie A; Bowden M; Lee GS; Kantoff PW; Sweeney CJ Clin Cancer Res; 2015 Dec; 21(24):5578-87. PubMed ID: 26289068 [TBL] [Abstract][Full Text] [Related]
13. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma. Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796 [TBL] [Abstract][Full Text] [Related]
14. Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms. Scott AJ; Arcaroli JJ; Bagby SM; Yahn R; Huber KM; Serkova NJ; Nguyen A; Kim J; Thorburn A; Vogel J; Quackenbush KS; Capasso A; Schreiber A; Blatchford P; Klauck PJ; Pitts TM; Eckhardt SG; Messersmith WA Mol Cancer Ther; 2018 Oct; 17(10):2112-2122. PubMed ID: 30026382 [TBL] [Abstract][Full Text] [Related]
15. Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts. Cornillie J; Wozniak A; Van Renterghem B; Van Winkel N; Wellens J; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P BMC Cancer; 2019 Jul; 19(1):724. PubMed ID: 31331295 [TBL] [Abstract][Full Text] [Related]
16. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism. Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035 [TBL] [Abstract][Full Text] [Related]
17. Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions. Dai J; Zhang H; Karatsinides A; Keller JM; Kozloff KM; Aftab DT; Schimmoller F; Keller ET Clin Cancer Res; 2014 Feb; 20(3):617-30. PubMed ID: 24097861 [TBL] [Abstract][Full Text] [Related]
18. Soft Tissue and Uterine Leiomyosarcoma. George S; Serrano C; Hensley ML; Ray-Coquard I J Clin Oncol; 2018 Jan; 36(2):144-150. PubMed ID: 29220301 [TBL] [Abstract][Full Text] [Related]
19. Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms. Yeh CC; Fan Y; Jiang L; Yang YL; He B; You L; Mann M Anticancer Res; 2015 Jun; 35(6):3167-73. PubMed ID: 26026076 [TBL] [Abstract][Full Text] [Related]
20. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Chang CC; Huang LH; Chiang W; Hsia SM Phytomedicine; 2018 Aug; 47():69-80. PubMed ID: 30166110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]